205 related articles for article (PubMed ID: 10477714)
1. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.
Ogilvy S; Metcalf D; Gibson L; Bath ML; Harris AW; Adams JM
Blood; 1999 Sep; 94(6):1855-63. PubMed ID: 10477714
[TBL] [Abstract][Full Text] [Related]
2. Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice.
Almarza E; Segovia JC; Guenechea G; Gómez SG; Ramírez A; Bueren JA
Exp Hematol; 2004 Apr; 32(4):360-4. PubMed ID: 15050746
[TBL] [Abstract][Full Text] [Related]
3. Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells.
Kim WI; Wiesner SM; Largaespada DA
Exp Hematol; 2007 Aug; 35(8):1231-9. PubMed ID: 17560009
[TBL] [Abstract][Full Text] [Related]
4. The Cebpa +37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells.
Guo H; Ma O; Friedman AD
J Leukoc Biol; 2014 Sep; 96(3):419-26. PubMed ID: 24868087
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment.
Ogilvy S; Elefanty AG; Visvader J; Bath ML; Harris AW; Adams JM
Blood; 1998 Jan; 91(2):419-30. PubMed ID: 9427694
[TBL] [Abstract][Full Text] [Related]
6. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.
Ogilvy S; Metcalf D; Print CG; Bath ML; Harris AW; Adams JM
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14943-8. PubMed ID: 10611317
[TBL] [Abstract][Full Text] [Related]
7. PU.1 regulates the expression of the vav proto-oncogene.
Denkinger DJ; Lambrecht TQ; Cushman-Vokoun AM; Kawahara RS
J Cell Biochem; 2002; 84(4):772-83. PubMed ID: 11835402
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice with hematopoietic and lymphoid specific expression of Cre.
de Boer J; Williams A; Skavdis G; Harker N; Coles M; Tolaini M; Norton T; Williams K; Roderick K; Potocnik AJ; Kioussis D
Eur J Immunol; 2003 Feb; 33(2):314-25. PubMed ID: 12548562
[TBL] [Abstract][Full Text] [Related]
9. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization.
Adams JM; Houston H; Allen J; Lints T; Harvey R
Oncogene; 1992 Apr; 7(4):611-8. PubMed ID: 1565462
[TBL] [Abstract][Full Text] [Related]
10. Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells.
Bockamp E; Antunes C; Maringer M; Heck R; Presser K; Beilke S; Ohngemach S; Alt R; Cross M; Sprengel R; Hartwig U; Kaina B; Schmitt S; Eshkind L
Blood; 2006 Sep; 108(5):1533-41. PubMed ID: 16675709
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA.
Wulf GM; Adra CN; Lim B
EMBO J; 1993 Dec; 12(13):5065-74. PubMed ID: 8262049
[TBL] [Abstract][Full Text] [Related]
12. VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.
Georgiades P; Ogilvy S; Duval H; Licence DR; Charnock-Jones DS; Smith SK; Print CG
Genesis; 2002 Dec; 34(4):251-6. PubMed ID: 12434335
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte integrin CD11b promoter directs expression in lymphocytes and granulocytes in transgenic mice.
Back A; East K; Hickstein D
Blood; 1995 Feb; 85(4):1017-24. PubMed ID: 7849290
[TBL] [Abstract][Full Text] [Related]
14. Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene.
Marodon G; Mouly E; Blair EJ; Frisen C; Lemoine FM; Klatzmann D
Blood; 2003 May; 101(9):3416-23. PubMed ID: 12511423
[TBL] [Abstract][Full Text] [Related]
15. A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1.
Zauli G; Furlini G; Vitale M; Re MC; Gibellini D; Zamai L; Visani G; Borgatti P; Capitani S; La Placa M
Blood; 1994 Sep; 84(6):1896-905. PubMed ID: 7521692
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the vav proto-oncogene by LKLF.
Denkinger DJ; Cushman-Vokoun AM; Kawahara RS
Gene; 2001 Dec; 281(1-2):133-42. PubMed ID: 11750135
[TBL] [Abstract][Full Text] [Related]
17. Genomic organization and regulation of the vav proto-oncogene.
Denkinger DJ; Borges CR; Butler CL; Cushman AM; Kawahara RS
Biochim Biophys Acta; 2000 Apr; 1491(1-3):253-62. PubMed ID: 10760587
[TBL] [Abstract][Full Text] [Related]
18. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
[TBL] [Abstract][Full Text] [Related]
19. Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells.
Hehner SP; Li-Weber M; Giaisi M; Dröge W; Krammer PH; Schmitz ML
J Immunol; 2000 Apr; 164(7):3829-36. PubMed ID: 10725744
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]